FENNEC PHARMACEUTICALS INC. (FENC) Market Cap & Valuation Ratios
FENNEC PHARMACEUTICALS INC. (FENC) has a market cap of $353.5M and a price-to-sales ratio of 6.0, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FENCFENNEC PHARMACEUTICALS INC.Follow FENC — free
—
Price chart with a free account
- Market cap
- 353.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Peers
biotechnology · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| FENC | 0.4 | — | 5.3 | — | — | +78% | -2% | -94% |
| CCCC | 0.4 | — | 8.5 | — | — | +2% | -319% | -84% |
| AVTX | 0.4 | — | — | — | — | -87% | — | -43% |
| MPLT | 0.4 | — | — | — | — | — | — | -88% |
| EDIT | 0.4 | — | 4.5 | — | — | +21% | -161% | — |
| RLMD | 0.3 | — | — | — | -13.2% | — | — | -62% |
| CAPR | 0.3 | — | — | — | — | — | — | -88% |
| ENTA | 0.3 | — | 2.3 | — | -10.9% | +0.7% | -90% | -115% |
| KYTX | 0.3 | — | — | — | — | — | — | -110% |
| AVIR | 0.3 | — | 0.3 | — | — | — | — | -91% |
| ZURA | 0.3 | — | — | — | — | — | — | — |
| Median of these 10 | — | 3.4 | — | -12.0% | +2% | -161% | -88% |
; EV/Sales 5.3 vs. 3.4.
Growth vs. price
each dot a company · hover or tap for valuesFENNEC PHARMACEUTICALS INC. — questions
- What is FENNEC PHARMACEUTICALS INC.'s market cap?
- $353.5M.
- What is FENNEC PHARMACEUTICALS INC.'s price-to-sales ratio?
- 6.0.
Every figure on this page comes from FENNEC PHARMACEUTICALS INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.